Article Details
Retrieved on: 2021-04-29 00:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Company's most advanced product candidate, YTX-7739, is currently in Phase 1 clinical development for Parkinson's disease. Yumanity's drug ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here